Facebook Linkedin Twitter
Inside Precision Medicine Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

Phase I clinical trials (Clinical trial)

Nerve cells affected by Alzheimer's disease, illustration
News & Features

Takeda Signs Deal Worth $2.2 Billion with AC Immune for Alzheimer’s Vaccine

Helen Albert -
0
Illustration of red blood cells moving through clogged artery to indicate cholesterol build up as a result of familial hypercholesterolemia and atherosclerosis, which are being targeted by Verve Therapeutics
News & Features

Verve Starts Second Human Cardiovascular Gene Therapy Trial

Helen Albert -
0
Brain Tumor
News & Features

mRNA Cancer Vaccine Reprograms Immune System to Tackle Glioblastoma

Sophia Ktori -
0
Sarcoma cells
News & Features

CAR T-Cell Therapy for Sarcoma Shows Early Promise

Helen Albert -
0
Sarcoma cells
News & Features

Next-Generation T Cell Therapy Shows Promise For Solid Tumors

Laura Cowen -
0
CAR T-Cell Immunotherapy
News & Features

CAR T-Cell Therapy Successfully Used to Treat Brain Tumors

Camille Mojica Rey, Ph.D. -
0
Little girl receives breathing treatment
News & Features

Sionna Raises $182M for Novel Cystic Fibrosis Drug Candidates

Malorye Branca -
0
Middle aged man with type 2 diabetes using blood sugar measurement device to monitor type 2 diabetes
News & Features

Insulin Delivered via Nano-Carriers May Pave Way for Oral Diabetes Treatment

Chris Anderson -
0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

BMS Dives Deeper into ADCs with Potential $8.4B SystImmune Deal

Malorye Branca -
0
Lymphoma cancer cell that can be targeted by CAR T-cell therapy
News & Features

CAR T-Cell Therapy with New Binding Method Shows Early Promise

Helen Albert -
0
1234Page 1 of 4

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine